...
首页> 外文期刊>Canadian Respiratory Journal >Role of Erythromycin-Regulated Histone Deacetylase-2 in Benign Tracheal Stenosis
【24h】

Role of Erythromycin-Regulated Histone Deacetylase-2 in Benign Tracheal Stenosis

机译:红霉素调节组蛋白脱乙酰酶-2在良性气管狭窄中的作用

获取原文

摘要

Objective. This study aims to explore the role of erythromycin-regulated histone deacetylase-2 in benign tracheal stenosis. Methods. The rabbit model of tracheal stenosis was established. The rabbits were randomly divided into 8 groups. Histone deacetylase-2 (HDAC2) expression was detected by immunofluorescence. The expression of type I collagen and type III collagen was detected by immunohistochemical method. The expression of TGF-β1, VEGF and IL-8 in serum and alveolar lavage fluid was detected by ELISA. The expression of HDAC2, TGF-β1, VEGF and IL-8 in bronchi of each group was detected by Western blotting method. Results. In Erythromycin (ERY) group, ERY?+?Budesonide group, ERY?+?Vorinostat group and ERY?+?Budesonide?+?Vorinostat group, the degree of bronchial stenosis was alleviated, and the mucosal epithelium was still slightly proliferated. The effect of ERY combined with other drugs was more obvious. The HDAC2 protein expression increased significantly in ERY group, ERY?+?Budesonide group and ERY?+?Budesonide?+?Vorinostat group and decreased significantly in Vorinostat group, the expression of collagen I and III decreased significantly in ERY group, ERY?+?Budesonide group and ERY?+?Budesonide?+?Vorinostat group (P0.05). The TGF-β1, IL-8 and VEGF levels decreased significantly in ERY group, ERY?+?Budesonide group, ERY?+?Vorinostat group and ERY?+?Budesonide?+?Vorinostat group (P0.05). Conclusions. Erythromycin inhibited inflammation and excessive proliferation of granulation tissue after tracheobronchial mucosal injury by up-regulating the expression of HDAC2, it promoted wound healing and alleviated tracheobronchial stenosis. When combined with budesonide, penicillin and other glucocorticoids and antibiotics, it had a good synergistic effect. However, vorinostat could attenuate erythromycin’s effect by down-regulating the expression of HDAC2. It may have good clinical application prospects in the treatment of tracheal stenosis.
机译:客观的。本研究旨在探讨红霉素调节的组​​蛋白脱乙酰酶-2在良性气管狭窄中的作用。方法。建立了气管狭窄的兔模型。将兔子随机分为8组。通过免疫荧光检测组蛋白脱乙酰酶-2(HDAC2)表达。通过免疫组织化学方法检测I型胶原蛋白和III型胶原蛋白的表达。通过ELISA检测到血清和肺泡灌洗液中TGF-β1,VEGF和IL-8的表达。通过蛋白质印迹法检测HDAC2,TGF-β1,VEGF和IL-8的表达。结果。在红霉素(ery)组中,美氏蛋白蛋白,+ +?+?+?+?+?+?+?+?vorinostat组,缓解支气管狭窄程度,粘膜上皮仍然略微增殖。红绿霉素与其他药物的影响更加明显。 HDAC2蛋白表达在红斑蛋白的蛋白质中显着增加,+ +?+α+?+?+?+?vorinostat组,在vorinostat组中显着显着,ILy族I和III的表达明显下降,+ ?水果苷群和红斑蛋白+?+ +?+?vorinostat组(P <0.05)。红绿群中的TGF-β1,IL-8和VEGF水平显着下降,IRYα+β-+α+β-+?+?vorinostat群和蛋白蛋白剂α+?+?+?vorinostat组(P <0.05)。结论。通过升压HDAC2的表达,促进伤口愈合和缓解气管支气管狭窄,红细胞霉素抑制气管粘膜损伤后的肉芽组织造粒组织过度增殖。与果树,青霉素和其他糖皮质激素和抗生素相结合时,它具有良好的协同效应。然而,Vorinostat通过降低HDAC2的表达,可以通过降低HDAC2的表达来衰减红霉素的效果。在治疗气管狭窄时可能具有良好的临床应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号